Orion gains on another outlook hike

Orion Oyj

16/01/2025 08:24

** Shares in Orion  ORNBV.HE  are up 4.5% after the Finnish
drugmaker hiked its 2024 revenue and operating profit outlook
    ** The company, which already raised its guidance in July
and September last year, now expects net sales of EUR 1.54
billion ($1.58 billion)
    ** Inderes expects significant forecast upgrades for the
coming years based on strong sales of prostate cancer treatment
Nubeqa, supported by high margins
    ** "Nubeqa now appears to have accelerated its long-awaited
broad-based market penetration," the analyst writes in a note
    ** Inderes adds that the dividend yield of almost 4% is
rather safe in the current outlook 
    ** The shares are on track for their best day since
September if the gains hold
    ($1 = 0.9717 euros)

(Reporting by Anna Chaberska)
((Anna.chaberska@thomsonreuters.com))